{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:24:09Z","timestamp":1762100649563},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1007\/s11883-007-0011-x","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T14:56:41Z","timestamp":1177513001000},"page":"145-153","source":"Crossref","is-referenced-by-count":30,"title":["Beyond lipids: The role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease"],"prefix":"10.1007","volume":"9","author":[{"given":"Terry A.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,26]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/01.CIR.0000132503.19410.6B","volume":"109","author":"K. He","year":"2004","unstructured":"He K, Song Y, Daviglus ML, et al.: Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004, 109:2705\u20132711.","journal-title":"Circulation"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"61i","DOI":"10.1016\/j.amjcard.2005.12.028","volume":"98","author":"T.A. Jacobson","year":"2006","unstructured":"Jacobson TA: Secondary prevention of coronary artery disease with omega-3 fatty acids. Am J Cardiol 2006, 98:61i\u201370i","journal-title":"Am J Cardiol"},{"key":"11_CR3","volume-title":"Effects of Omega-3 Fatty Acids On Cardiovascular Risk Factors and Intermediate Markers Of Cardiovascular Disease: Summary, Evidence Report\/Technology Assessment No. 93","author":"E. Balk","year":"2004","unstructured":"Balk E, Chung M, Lichtenstein A, et al.; for the Tufts-New England Medical Center Evidence-Based Practice Center, Boston, MA: Effects of Omega-3 Fatty Acids On Cardiovascular Risk Factors and Intermediate Markers Of Cardiovascular Disease: Summary, Evidence Report\/Technology Assessment No. 93. Rockville, MD: Agency for Healthcare Research and Quality; March 2004. AHRQ Publication No. 04-E010-2."},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","volume":"354","author":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico","year":"1999","unstructured":"Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico (GISSI)-Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction (results of the GISSI-Prevenzione trial). [published correction appears in Lancet 2001;357:642] Lancet 1999, 354:447\u2013455.","journal-title":"Lancet"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archinte.165.7.725","volume":"165","author":"M. Studer","year":"2005","unstructured":"Studer M, Briel M, Leimenstoll B, et al.: Effect of different antilipidemic agents and diets on mortality (a systematic review). Arch Intern Med 2005, 165:725\u2013730.","journal-title":"Arch Intern Med"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.38755.366331.2F","volume":"332","author":"L. Hooper","year":"2006","unstructured":"Hooper L, Thompson RL, Harrison RA, et al.: Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 2006, 332:752\u2013760.","journal-title":"BMJ"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.296.15.1885","volume":"296","author":"D. Mozaffarian","year":"2006","unstructured":"Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296:1885\u20131899.","journal-title":"JAMA"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.ejcn.1601539","volume":"57","author":"M.L. Burr","year":"2003","unstructured":"Burr ML, Ashfield-Watt PA, Dunstan FD, et al.: Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003, 57:193\u2013200.","journal-title":"Eur J Clin Nutr"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-8703(03)00367-3","volume":"146","author":"M. Yokoyama","year":"2003","unstructured":"Yokoyama M, Origasa H; JELIS Investigators: Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia (rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS)). Am Heart J 2003, 146:613\u2013620.","journal-title":"Am Heart J"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejheart.2005.12.003","volume":"8","author":"J.G. Cleland","year":"2006","unstructured":"Cleland JG, Freemantle N, Coletta AP, Clark AL: Clinical trials update from the American Heart Association: REPAIRAMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 2006, 8:105\u2013110.","journal-title":"Eur J Heart Fail"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(89)90828-3","volume":"2","author":"M.L. Burr","year":"1989","unstructured":"Burr ML, Fehily AM, Gilbert JF, et al.: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction (Diet and Reinfarction Trial (DART)). Lancet 1989, 2:757\u2013761.","journal-title":"Lancet"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","volume":"105","author":"R. Marchioli","year":"2002","unstructured":"Marchioli R, Barzi F, Bomba E, et al.: Early protection against sudden death by n-3 fatty acids after myocardial infarction (time course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI)-Prevenzione). Circulation 2002, 105:1897\u20131903.","journal-title":"Circulation"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ejheart.2005.04.008","volume":"7","author":"A. Macchia","year":"2005","unstructured":"Macchia A, Levantesi G, Franzosi MG, et al.: Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail 2005, 7:904\u2013909.","journal-title":"Eur J Heart Fail"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1001\/jama.293.23.2884","volume":"293","author":"M.H. Raitt","year":"2005","unstructured":"Raitt MH, Connor WE, Morris C, et al.: Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators (a randomized controlled trial). JAMA 2005, 293:2884\u20132891.","journal-title":"JAMA"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/CIRCULATIONAHA.105.549527","volume":"112","author":"A. Leaf","year":"2005","unstructured":"Leaf A, Albert CM, Josephson M, et al.: Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005, 112:2762\u20132768.","journal-title":"Circulation"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.295.22.2613","volume":"295","author":"I.A. Brouwer","year":"2006","unstructured":"Brouwer IA, Zock PL, Camm AJ, et al.: Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 2006, 295:2613\u20132619.","journal-title":"JAMA"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.jacc.2005.02.079","volume":"45","author":"L. Calo","year":"2005","unstructured":"Calo L, Bianconi L, Colivicchi F, et al.: N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery (a randomized, controlled trial). J Am Coll Cardiol 2005, 45:1723\u20131728.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl","key":"11_CR18","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1007\/BF02562284","volume":"34","author":"A. Leaf","year":"1999","unstructured":"Leaf A, Kang JX, Xiao YF, Billman GE: n-3 Fatty acids in the prevention of cardiac arrhythmias. Lipids 1999, 34(Suppl):S187\u2013S189.","journal-title":"Lipids"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1073\/pnas.89.5.1760","volume":"89","author":"H. Hallaq","year":"1992","unstructured":"Hallaq H, Smith TW, Leaf A: Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci U S A 1992, 89:1760\u20131764.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl","key":"11_CR20","doi-asserted-by":"crossref","first-page":"208S","DOI":"10.1093\/ajcn\/71.1.208S","volume":"71","author":"D.S. Siscovick","year":"2000","unstructured":"Siscovick DS, Raghunathan T, King I, et al.: Dietary intake of long-chain omega-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr 2000, 71(Suppl):208S\u2013212S.","journal-title":"Am J Clin Nutr"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.amjcard.2005.07.071","volume":"96","author":"C.R. Harper","year":"2005","unstructured":"Harper CR, Jacobson TA: Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am J Cardiol 2005, 96:1521\u20131529.","journal-title":"Am J Cardiol"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","volume":"106","author":"P.M. Kris-Etherton","year":"2002","unstructured":"Kris-Etherton PM, Harris WS, Appel LJ, for the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747\u20132757.","journal-title":"Circulation"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.105.556886","volume":"112","author":"D. Mozaffarian","year":"2005","unstructured":"Mozaffarian D, Geelen A, Brouwer IA, et al.: Effect of fish oil on heart rate in humans (a meta-analysis of randomized controlled trials). Circulation 2005, 112:1945\u20131955.","journal-title":"Circulation"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"C.N. Serhan","year":"2002","unstructured":"Serhan CN, Hong S, Gronert K, et al.: Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals, J Exp Med 2002 196:1025\u20131037.","journal-title":"J Exp Med"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.atc.2006.01.003","volume":"24","author":"C.N. Serhan","year":"2006","unstructured":"Serhan CN: Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin 2006, 24:341\u2013364.","journal-title":"Anesthesiol Clin"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCULATIONAHA.105.581355","volume":"113","author":"H. Iso","year":"2006","unstructured":"Iso H, Kobayashi M, Ishihara J, et al.: Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006, 113:195\u2013202.","journal-title":"Circulation"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","volume":"368","author":"H. Nakamura","year":"2006","unstructured":"Nakamura H, Arakawa K, Itakura H, et al.; MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006, 368:1155\u20131163.","journal-title":"Lancet"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ajcn\/76.2.326","volume":"76","author":"P. Nestel","year":"2002","unstructured":"Nestel P, Shige H, Pomeroy S, et al.: The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 2002, 76:326\u2013330.","journal-title":"Am J Clin Nutr"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s11745-001-0831-4","volume":"36","author":"F. Thies","year":"2001","unstructured":"Thies F, Miles EA, Nebe-von-Caron G, et al.: Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001, 36:1183\u20131193.","journal-title":"Lipids"},{"issue":"6Suppl","key":"11_CR30","doi-asserted-by":"crossref","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","volume":"83","author":"P.C. Calder","year":"2006","unstructured":"Calder PC: n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(6 Suppl):1505S\u20131519S.","journal-title":"Am J Clin Nutr"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"The Cardiac Arrhythmia Suppression Trial","year":"1989","unstructured":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: effect of encainide or flecainide on mortality in a randomized trial of arrhythmic suppression after myocardial infarction. N Engl J Med 1989, 321:406\u2013412.","journal-title":"N Engl J Med"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejheart.2004.03.001","volume":"6","author":"L. Tavazzi","year":"2004","unstructured":"Tavazzi L, Tognoni G, Franzosi MG, et al.: Rationale and design of the GISSI Heart Failure trial (a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure). Eur J Heart Fail 2004, 6:635\u2013641.","journal-title":"Eur J Heart Fail"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-007-0011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-007-0011-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-007-0011-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:35:31Z","timestamp":1559432131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-007-0011-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11883-007-0011-x","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}